title: [Aspergillus peritonitis--a case report].
abstract: The incidence of fungal infections such as Aspergillosis is increasing among immunocompromised patients. Demand for diagnosis of mycotic diseases is steadily raising among clinicians and treatment of these patients represents a continually growing challenge. The authors present a case of a 53-year-old male patient with Aspergillus peritonitis. This case deserves attention because its extreme rarity in the medical literature and complex therapy of coinfections during the hospital stay which was difficult and relatively expensive. The importance of consultation and microbiological sampling is emphasized.
authors.affiliation: Bács-Kiskun Megyei Önkormányzat Kórháza Kórházhigiénés Osztály 6000 Kecskemét Nyíri út 38. patyim@kmk.hu
authors.forename: Márta
authors.initials: M
authors.lastname: Patyi
authors.forename: Mihály
authors.initials: M
authors.lastname: Svébis
mesh_terms: D000666:Amphotericin B / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use*; D001228:Aspergillosis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D002981:Clindamycin / Q000627:therapeutic use; D003428:Cross Infection / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology; D006801:Humans; D016867:Immunocompromised Host; D008297:Male; D000077731:Meropenem; D008875:Middle Aged; D010538:Peritonitis / Q000150:complications / Q000188:drug therapy / Q000382:microbiology; D013369:Subphrenic Abscess / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology; D013845:Thienamycins / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D013845:Thienamycins; D002981:Clindamycin; D000666:Amphotericin B; D000077731:Meropenem